Amlodipine 2.5 mg

DRUG4 trials

Sponsors

Zentiva k.s., Boehringer Ingelheim, Novartis Pharmaceuticals, Novartis

Conditions

Essential HypertensionHypertensionPatients with moderate or severe oedema on a long-term treatment with amlodipine

Phase 2

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

CompletedNCT00425373

Novartis PharmaceuticalsEssential Hypertension

Start: 2006-11-30End: 2008-03-31Updated: 2011-04-29

Peripheral Edema Resolution evaluated in patients switched from amlodipine to Levamlodipine (PERLA)

CompletedCTIS2024-511312-24-00

Zentiva k.s.Patients with moderate or severe oedema on a long-term treatment with amlodipine

Start: 2024-09-25End: 2025-07-31Target: 60Updated: 2025-04-10

Phase 3

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension

CompletedNCT00281580

Boehringer IngelheimHypertension

Start: 2006-04-30Updated: 2014-03-27

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

CompletedNCT01237223

NovartisEssential Hypertension

Start: 2010-10-31End: 2011-05-31Updated: 2012-06-13

Related Papers

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study

Drug Design Development and Therapy2020-12-0125 citations